Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions

GLIA

Volumn 63, Issue 10, 2015, Pages 1714-1728

  Furusho, Miki ^a   Roulois, Aude J ^b   Franklin, Robin J M ^b   Bansal, Rashmi ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Myelin; Oligodendrocyte; Remyelination

Indexed keywords

CUPRIZONE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MYELIN; MYELIN PROTEIN; 2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CHELATING AGENT; CNP PROTEIN, MOUSE; FGFR1 PROTEIN, MOUSE; FGFR2 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; OLIG1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LINEAGE; CELL REGENERATION; CELL SURVIVAL; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; FOREBRAIN; MOUSE; MYELIN SHEATH; MYELINATION; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMYELINIZATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CHEMICALLY INDUCED; CONVALESCENCE; DEMYELINATING DISEASE; DISEASE MODEL; DRUG EFFECTS; GENETICS; METABOLISM; NEWBORN; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; TRANSGENIC MOUSE;

2',3'-CYCLIC NUCLEOTIDE 3'-PHOSPHODIESTERASE; ANIMALS; ANIMALS, NEWBORN; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; CHELATING AGENTS; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FIBROBLAST GROWTH FACTORS; LYSOPHOSPHATIDYLCHOLINES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGODENDROGLIA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RECOVERY OF FUNCTION; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 84938972696     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22838     Document Type: Article

References (56)

1. Armstrong RC, Le TQ, Flint NC, Vana AC, Zhou YX. 2006. Endogenous cell repair of chronic demyelination. J Neuropathol Exp Neurol 65:245-256.
2. Armstrong RC, Le TQ, Frost EE, Borke RC, Vana AC. 2002. Absence of fibroblast growth factor 2 promotes oligodendroglial repopulation of demyelinated white matter. J Neurosci 22:8574-8585.
3. Baas D, Barnstable CJ. 1998. HPC-7: A novel oligodendrocyte lineage protein, which appears prior to galactcerebroside. Glia 23:169-179.
4. Bansal R. 2002. Fibroblast growth factors and their receptors in oligodendrocyte development: Implications for demyelination and remyelination. Dev Neurosci 24:35-46.
5. Bansal R, Kumar M, Murray K, Morrison RS, Pfeiffer SE. 1996. Regulation of FGF receptors in the oligodendrocyte lineage. Mol Cell Neurosci 7:263-275.
6. Bansal R, Pfeiffer SE. 1997. FGF-2 converts mature oligodendrocytes to a novel phenotype. J Neurosci Res 50:215-228.
7. Bansal R, Stefansson K, Pfeiffer SE. 1992. Proligodendroblast antigen (POA), a developmental antigen expressed by a007/O4-positive oligodendrocyte progenitors prior to the appearance of sulfatide and galactocerebroside. J Neurochem 58:2221-2229.
8. Clemente D, Ortega MC, Arenzana FJ, de Castro F. 2011. FGF-2 and Anosmin-1 are selectively expressed in different types of multiple sclerosis lesions. J Neurosci 31:14899-14909.
9. Copelman CA, Cuzner ML, Groome N, Diemel LT. 2000. Temporal analysis of growth factor mRNA expression in myelinating rat brain aggregate cultures: increments in CNTF, FGF-2, IGF-I, and PDGF-AA mRNA are induced by antibody-mediated demyelination. Glia 30:342-351.
10. Dehghan S, Javan M, Pourabdolhossein F, Mirnajafi-Zadeh J, Baharvand H. 2012. Basic fibroblast growth factor potentiates myelin repair following induction of experimental demyelination in adult mouse optic chiasm and nerves. J Mol Neurosci 48:77-85.
11. Dutta R, Trapp BD. 2011. Mechanisms of neuronal dysfunction and degeneration in multiple sclerosis. Prog Neurobiol 93:1-12.
12. Fortin D, Rom E, Sun H, Yayon A, Bansal R. 2005. Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J Neurosci 25:7470-7479.
13. Franklin RJM. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
14. Franklin RJM, ffrench-Constant C. 2008. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 9:839-855.
15. Franklin RJM, Gallo V. 2014. The translational biology of remyelination: past, present, and future. GLIA 62:1905-1915.
16. Furusho M, Dupree JL, Bryant M, Bansal R. 2009. Disruption of fibroblast growth factor receptor signaling in nonmyelinating schwann cells causes sensory axonal neuropathy and impairment of thermal pain sensitivity. J Neurosci 29:1608-1614.
17. Furusho M, Dupree JL, Nave KA, Bansal R. 2012. Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness. J Neurosci 32:6631-6641.
18. Furusho M, Kaga Y, Ishii A, Hébert JM, Bansal R. 2011. Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain. J Neurosci 31:5055-5066.
19. Gehrmann J, Lannes-Vieira J, Wekerle H. 1996. Differential expression of fibroblast growth factor-2 and receptor by glial cells in experimental autoimmune encephalomyelitis (EAE). Glia 16:93-100.
20. Guardiola-Diaz HM, Ishii A, Bansal R. 2012. Erk1/2 MAPK and mTOR signaling sequentially regulates progression through distinct stages of oligodendrocyte differentiation. Glia 60:476-486.
21. Gudi V, Škuljec J, Yildiz Ö, Frichert K, Skripuletz T, Moharregh-Khiabani D, Voss E, Wissel K, Wolter S, Stangel M. 2011. Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS One 6:e22623.
22. Harsan LA, Steibel J, Zaremba A, Agin A, Sapin R, Poulet P, Guignard B, Parizel N, Grucker D, Boehm N, Miller RH, Ghandour MS. 2008. Recovery from chronic demyelination by thyroid hormone therapy: Myelinogenesis induction and assessment by diffusion tensor magnetic resonance imaging. J Neurosci 28:14189-14201.
23. Hibbits N, Yoshino J, Le TQ, Armstrong RC. 2012. Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination. ASN Neuro 4:e00100.
24. Hinks GL, Franklin RJM. 1999. Distinctive patterns of PDGF-a, FGF-2, IGF-I, and TGF-b1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14:153-168.
25. Hiremath MM, Saito Y, Knapp GW, Ting JP-Y, Suzuki K, Matsushima GK. 1998. Microglia/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 92:38-49.
26. Itoh N, Ornitz DM. 2004. Evolution of the fgf and fgfr gene families. Trends Genet 20:563-569.
27. Kaga Y, Shoemaker WJ, Furusho M, Bryant M, Rosenbluth J, Pfeiffer SE, Oh L, Rasband M, Lappe-Siefke C, Yu K, Ornitz DM, Nave KA, Bansal R. 2006. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with cnp1 inactivation. J Neurosci 26:12339-12350.
28. Kluver H, Barrera E. 1953. A method for the combined staining of cells and fibers in the nervous system. J Neuropathol Exp Neurol 12:400-403.
29. Kumar S, Biancotti JC, Yamaguchi M, de Vellis J. 2007. Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model. Neurochem Res 32:783-797.
30. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave KA. 2003. Disruption of cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33:366-374.
31. Lindner M, Fokuhl J, Linsmeier F, Trebst C, Stangel M. 2009. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination. Neurosci Lett 453:120-125.
32. Liu X, Mashour GA, Webster HF, Kurt A. 1998. Basic FGF and FGF receptor 1 are expressed in microglia during experimental autoimmune encephalomyelitis: Temporally distinct expression of midkine and pleiotrophin. Glia 24:390-397.
33. Lu QR, Sun T, Zhu Z, Ma N, Garcia M, Stiles CD, Rowitch DH. 2002. Common developmental requirement for olig function indicates a motor neuron/oligodendrocyte connection. Cell 109:75-86.
34. Madiai F, Hussain SR, Goetti VM, Burry RW, Stephens RL Jr, Hackshaw KV. 2003. Upregulation of FGF-2 in reactive spinal cord astrocytes following unilateral lumbar spinal nerve ligation. Exp Brain Res 148:366-376.
35. Mason JL, Langaman C, Morell P, Suzuki K, Matsushima GK. 2001. Episodic demyelination and subsequent remyelination within the murine central nervous system: Changes in axonal calibre. Neuropathol Appl Neurobiol 27:50-58.
36. Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK. 2004. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol 164:1673-1682.
37. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
38. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA. 1990. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5:603-614.
39. Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC. 2000. Fibroblast growth factor 2 (fgf2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 62:24-56.
40. Miyake S, Makimura M, Kanegae Y, Harada S, Sato Y, Takamori K, Tokuda C, Saito I. 1996. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc Natl Acad Sci USA 93:1320-1324.
41. Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ. 2011. How factors secreted from astrocytes impact myelin repair. J Neurosci Res. 89:13-21.
42. Oh LY, Denninger A, Colvin JS, Vyas A, Tole S, Ornitz DM, Bansal R. 2003. Fibroblast growth factor receptor 3 signaling regulates the onset of oligodendrocyte terminal differentiation. J Neurosci 23:883-894.
43. O'Leary MT, Hinks GL, Charlton HM, Franklin RJ. 2002. Increasing local levels of IGF-I mRNA expression using adenoviral vectors does not alter oligodendrocyte remyelination in the CNS of aged rats. Mol Cell Neurosci 19:32-42.
44. Ornitz DM, Xu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, Goldfarb M. 1996. Receptor specificity of the fibrobrast growth factor family. J Biol Chem 271:15292-15297.
45. Pavelko KD, van Engelen BG, Rodriguez M. 1998. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci 18:2498-2505.
46. Pirvola U, Ylikoski J, Trokovic R, Hébert JM, McConnell SK, Partanen J. 2002. Fgfr1 is required for the development of the auditory sensory epithelium. Neuron 35:671-680.
47. Rottlaender A, Villwock H, Addicks K, Kuerten S. 2011. Neuroprotective role of fibroblast growth factor-2 in experimental autoimmune encephalomyelitis. Immunology 133:370-378.
48. Ruffini F, Furlan R, Poliani PL, Brambilla E, Marconi PC, Bergami A, Desina G, Glorioso JC, Comi G, Martino G. 2001. Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice. Gene Ther 8:1207-1213.
49. Shields SA, Gilson JM, Blakemore WF, Franklin RJ. 1999. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 28:77-83.
50. Tourbah A, Baron-Van Evercooren A, Oliver L, Raulais D, Jeanny JC, Gumpel M. 1992. Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: Immunohistochemical study. J Neurosci Res 33:47-59.
51. Vana AC, Flint NC, Harwood NE, Le TQ, Fruttiger M, Armstrong RC. 2007. Platelet-derived growth factor promotes repair of chronically demyelinated white matter. J Neuropathol Exp Neurol 66:975-988.
52. Voss EV, Škuljec J, Gudi V, Skripuletz T, Pul R, Trebst C, Stangel M. 2012. Characterisation of microglia during de- and remyelination: Can they create a repair promoting environment? Neurobiol Dis 45:519-528.
53. Wang SJ, Furusho M, D'Sa C, Kuwada S, Conti L, Morest DK, Bansal R. 2009. Inactivation of fibroblast growth factor receptor signaling in myelinating glial cells results in significant loss of adult spiral ganglion neurons accompanied by age-related hearing impairment. J Neurosci Res 87:3428-3437.
54. Yan D, Chen D, Cool SM, van Wijnen AJ, Mikecz K, Murphy G, Im HJ. 2011. Fibroblast growth factor receptor 1 is principally responsible for fibroblast growth factor 2-induced catabolic activities in human articular chondrocytes. Arthritis Res Ther 13:R130.
55. Yu K, Xu J, Liu Z, Sosic D, Shao J, Olson EN, Towler DA, Ornitz DM. 2003. Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130:3063-3074.
56. Zhou YX, Pannu R, Le TQ, Armstrong RC. 2012. Fibroblast growth factor 1 (fgfr1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination. Neurobiol Dis 45:196-205.